Skip to main content

Table 1 Patient and tumor characteristics

From: Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer

Characteristics

No.

%

Age

  

 Median

65 years

 Range

44–86 years

Gender

  

 Male

72

80.9

 Female

17

19.1

Karnofsky performance status

  

 90 %

72

80.9

  < 90 %

17

19.1

Location of tumor

  

 Cervix

5

5.6

 Upper thorax

15

16.9

 Middle thorax

46

51.7

 Lower thorax

23

25.8

Clinical T stage

  

 cT1

22

24.7

 cT2

7

7.9

 cT3

34

38.2

 cT4

26

29.2

Clinical N stage

  

 cN0

26

29.2

 cN1

29

32.6

 cN2

23

25.8

 cN3

11

12.4

Clinical M stage

  

 cM0

81

91.0

 cM1

8

9.0

Histology type

  

 Adenocarcinoma

3

3.4

 Squamous cell carcinoma

86

96.6